Shuang Wang*, Daqi Zhao†, Ruihua Tian*, Hailong Shi*, Xiangming Chen*, Wenzhi Liu*, Lin Wei*
Oncology Research, Vol.23, No.4, pp. 197-203, 2015, DOI:10.3727/096504016X14537290676919
Abstract Gastric cancer is the fourth most common type of cancer and second leading cause of cancer-related death in
the world. Since patients are often diagnosed at a late stage, very few effective therapies are left in the arsenal.
FGF19, as a hormone, has been reported to promote tumor growth in various types of cancer; however, its
function in gastric cancer remains unknown. In the current study, we showed that FGF19 is overexpressed in
gastric cancer and is associated with depth of invasion, lymph node metastasis, and TNM stage. In addition, in
vitro experiments demonstrated that More >
Login
Register
